TheEdgeResearch
Home / Stocks / RMRK

Rimrock Gold Corp. (RMRK)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▲ +0.00%
Market Cap
$234,228
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
-0.07
52-Wk Range
0.0001-0.0005
CEO
Jordan Starkman
Country
US
Currency
USD

Rimrock Gold Corp. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $234,228. On trailing twelve-month figures it carries a trailing P/E of 5.73, a net margin of 0.0%. Its beta of -0.07 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
5.73
Price / Sales
0.00
Price / Book
-3.26
EV / EBITDA
1.90
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2009-02-09
Headquarters
Las Vegas, NV, US
About Rimrock Gold Corp.

Rimrock Gold Corp., through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts. The company was incorporated in 2007 and is based in Las Vegas, Nevada.

Comparable companies

Rimrock Gold Corp. is most often compared with the following Healthcare names:

ACUSAQSZFBLFECBDLDVLPHPMMIVIXFNEPTFSHWZVRSYF
More research on RMRK
RMRK technical analysis RMRK TheEdge Score Compare against peers
Open full interactive analysis & DCF →